BIOTECH ASSISTANT / FIELD NOTES

Vitamin B6 ternary eutectics change solubility and permeability in two BCS IV drugs

Academic source · Crystal Growth & Design (ACS)

Source published:

Site published: 2026-11-03 · Updated: 2026-11-03

Explore this article with AI

This source is linked automatically. Choose a question to get started.

Ask AI ↗

What changed

Researchers combined pyridoxine hydrochloride with mesalamine or acetazolamide and p-aminobenzoic acid to prepare ternary eutectic solids. The systems altered pH-dependent solubility and membrane permeability. Characterization distinguished a physical mixture from a cocrystal-containing eutectic, emphasizing that multicomponent formulations can have different phase identities. The reported laboratory results do not establish human bioavailability improvements.

Why it may matter

The work suggests a formulation route for difficult drugs while underscoring the need for phase identification and in vivo confirmation.

The interpretation above is analysis, not a conclusion attributed to the original source.

Read the original source ↗

Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections

Pharmaceutical solid state

Related updates

Frontiers in Chemistry

Review examines cocrystal performance and barriers to clinical translation

A Frontiers in Chemistry review examines pharmaceutical cocrystals as a way to modify dissolution and related biopharmaceutical properties without changing an API's chemical identity. The abstract distinguishes solubility-limited BCS II drugs from permeability-limited BCS IV drugs. It highlights gastrointestinal instability, manufacturing reproducibility, coformer selection, and limited pharmacokinetic evidence. Much of the reported performance evidence remains preclinical.

AAPS Open

Compaction density reveals reversible urea polymorph changes under pressure

An AAPS Open study used a compaction simulator to track reversible density changes in urea between 600 and 900 MPa, consistent with its known form I-to-III transformation. The original abstract proposes in-die density monitoring as a material-sparing screen for pressure-induced phase changes. Applicability depends on a sufficiently large density difference; urea is the demonstrated model compound.

Continue your research

Explore company filters, side-by-side comparisons, private bookmarks, and member discussions.

Open free member tools ↗
AI assistant ↗